Log in to search using one of your social media accounts:

 

Criteria for Prostate Cancer Trials Disproportionately Exclude Blacks
Trials sponsored by academic investigators, cooperative groups more likely to use these criteria (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - February 12, 2018 Category: Cancer & Oncology Tags: Oncology, Pathology, Pharmacy, Urology, Journal, Source Type: news

Imaging system helps determine chemo efficacy against breast cancer
A new optical imaging system helps determine which breast cancer patients will best respond to chemotherapy, according to researchers at Columbia University. (Source: Health News - UPI.com)
Source: Health News - UPI.com - February 12, 2018 Category: Consumer Health News Source Type: news

Contracting an STI could be deadly this Valentine ’s Day
Dr Tina Joshi, a lecturer in molecular microbiology at Plymouth University, spoke of the threat of antibiotic resistance - expected to kill more people than cancer in the next 30 years - in terms of STIs. (Source: the Mail online | Health)
Source: the Mail online | Health - February 12, 2018 Category: Consumer Health News Source Type: news

Abraham Lincoln Was Our Tallest President Ever. This May Be Why
Abraham Lincoln, who would have celebrated his 209th birthday on Feb. 12, left behind an impressive legacy during his time in office — but many Americans still associate the 16th president, first and foremost, with his towering height. Standing 6’4″, Lincoln is, to this day, the tallest president ever, edging out Lyndon Johnson by a full inch. Height wasn’t Lincoln’s only distinguishing physical characteristic. While he was in office, a journalist described the president’s “long pendulous arms” and “hands of extraordinary dimensions…far exceeded in proportion by ...
Source: TIME: Health - February 12, 2018 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Abraham Lincoln healthytime onetime Source Type: news

Researchers develop novel immunotherapy to target colorectal cancer
A Yale-led research team has developed an antibody that blocks tumors in animal models of colorectal cancer. (Source: Yale Science and Health News)
Source: Yale Science and Health News - February 12, 2018 Category: Universities & Medical Training Source Type: news

Ky. Medicaid expansion improves breast cancer care
Early data from Medicaid expansion in Kentucky since the passage of the Affordable...Read more on AuntMinnie.comRelated Reading: More women get breast screening after ACA bans copays Tax reform bill overturns ACA's individual mandate Study: ACA led to more early-stage cancer diagnoses CMS: State healthcare spending growth on the rise (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 12, 2018 Category: Radiology Source Type: news

Medical News Today: Cancer: Targeting protein may stop tumors from spreading
Researchers have now taken a major step in the prevention of cancer metastasis by identifying and targeting a protein that helps tumors to spread. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - February 12, 2018 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news

Lung cancer drug resistance explained by computer simulations
Scientists from the Universities of Bristol and Parma, Italy, have used molecular simulations to understand resistance to osimertinib - an anticancer drug used to treat types of lung cancer. (Source: University of Bristol news)
Source: University of Bristol news - February 12, 2018 Category: Universities & Medical Training Tags: Research; Faculty of Science, Faculty of Science, School of Chemistry; Press Release Source Type: news

' Cinderella' Cancer Gets Trial With Fairy-tale Ending?'Cinderella' Cancer Gets Trial With Fairy-tale Ending?
Upper tract bladder cancer is a rare malignancy and as such is difficult to study in a phase 3 clinical trial. But a determined group of investigators pulled it off and appear to have changed practice.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 12, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Cintas Corp.'s Farmer family donates $10M to boost cancer care in Cincinnati
The Farmer Family Foundation, whose trustees include the CEO of Cintas Corp., revealed today it is donating $10 million to help the Cincinnati Cancer Center seek designation as a national hub for cancer research. “It’s imperative that we join this effort … to make both an immediate and long-term impact on the fight against cancer right here in our community,” said Scott Farmer, CEO of Mason-based Cintas (Nasdaq: CTAS) and a trustee of the Farmer Family Foundation. “Cancer touches all of… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - February 12, 2018 Category: American Health Authors: Barrett J. Brunsman Source Type: news

' Cinderella' Cancer Gets Trial With Fairy-tale Ending'Cinderella' Cancer Gets Trial With Fairy-tale Ending
Upper tract bladder cancer is a rare malignancy and as such is difficult to study in a phase 3 clinical trial. But a determined group of investigators pulled it off and appear to have changed practice.Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 12, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

A&E, RTT and cancer waits - January 2018: explore the maps
NHS waiting lists around England, updated for January 2018. (Source: HSJ)
Source: HSJ - February 12, 2018 Category: UK Health Source Type: news

Cancer Risk With Old Age Due to Immune System Decline? Cancer Risk With Old Age Due to Immune System Decline?
The increase in cancer incidence with age may be more closely related to age-related declines in the immune system than to the steady accumulation of genetic mutations, suggests a mathematical analysis.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 12, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Pennsylvania needs more doctors for medical marijuana program
About 355 doctors in Pennsylvania have been approved to certify patients for the state's medical marijuana program, according to Trib Total Media. But more than 16,000 residents have registered for the program to treat 17 state-approved illnesses and ailments, like Crohn's disease, cancer and Parkinson's disease. About 3,300 have been certified to receive medical marijuana, according to the Trib. About 300 more doctors have registered to ta ke the four-hour training course for certification into… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - February 12, 2018 Category: American Health Authors: Stacey Federoff Source Type: news

Photos show the reality of battling breast cancer
Helen Sheil, 76, from Queensland, had both breasts removed after being diagnosed with the disease 20 years ago, however, the condition has returned and spread to the mother-of-two's bones. (Source: the Mail online | Health)
Source: the Mail online | Health - February 12, 2018 Category: Consumer Health News Source Type: news

DNA Robots Target Cancer
Researchers use DNA origami to generate tiny mechanical devices that deliver a drug that cuts off the blood supply to tumors in mice. (Source: The Scientist)
Source: The Scientist - February 12, 2018 Category: Science Tags: Daily News Source Type: news

Experts develop revolutionise skin cancer jab
British scientists have created a cancer vaccine that fights the most deadly type of skin cancer – and learned how to predict who it will work for. (Source: the Mail online | Health)
Source: the Mail online | Health - February 12, 2018 Category: Consumer Health News Source Type: news

Using injectable self-assembled nanomaterials for sustained delivery of drugs
Because they can be programmed to travel the body and selectively target cancer and other sites of disease, nanometer-scale vehicles called nanocarriers can deliver higher concentrations of drugs to bombard specific areas of the body while minimizing systemic side effects. Nanocarriers can also deliver drugs and diagnostic agents that are typically not soluble in water or blood as well as significantly decrease the effective dosage. (Source: World Pharma News)
Source: World Pharma News - February 12, 2018 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Cancer-Fighting Nanorobots Programmed to Seek and Destroy Tumors
In a major advancement in nanomedicine, Arizona State University (ASU) scientists, in collaboration with researchers from the National Center for Nanoscience and Technology (NCNST), of the Chinese Academy of Sciences, have successfully programmed nanorobots to shrink tumors by cutting off their blood supply. (Source: eHealth News EU)
Source: eHealth News EU - February 12, 2018 Category: Information Technology Tags: Featured Research Research and Development Source Type: news

Pancreatic cancer WARNING – why you should never ignore back pain
CANCER symptoms vary depending on where the tumour is in the body. But, you should never ignore back pain, because it could be a sign of pancreatic cancer. (Source: Daily Express - Health)
Source: Daily Express - Health - February 12, 2018 Category: Consumer Health News Source Type: news

Cancer Risk in Old Age and Immune System Decline
Cancer Risk With Old Age Due to Immune System Decline? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - February 12, 2018 Category: General Medicine Source Type: news

Head and Neck Cancer
Title: Head and Neck CancerCategory: Diseases and ConditionsCreated: 9/19/2007 12:00:00 AMLast Editorial Review: 2/12/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - February 12, 2018 Category: Cancer & Oncology Source Type: news

Adding blood test to US improves liver cancer diagnosis
Performing a blood test in addition to an ultrasound exam improved the sensitivity...Read more on AuntMinnie.comRelated Reading: Lancet: Cancer survival rates improve but vary widely US elastography for liver evaluation: Worth the cost? JAMA: Cancer deaths fall 20% in U.S. since 1980 Cancer mortality continues to drop in U.S. HCC screening boosts survival rate in cirrhosis patients (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 12, 2018 Category: Radiology Source Type: news

Drug shortages burden U.S. health care system
Shortages go further than IV bags from Puerto Rico, with drugs for cancer, diabetes and heart disease seen at risk (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - February 12, 2018 Category: Consumer Health News Source Type: news

Prostate Cancer Immunotherapy Prostate Cancer Immunotherapy
Find out more about the current landscape for prostate cancer immunotherapy and learn about potential treatment strategies.Current Opinion in Urology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 12, 2018 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Full integration of digital breast tomosynthesis reduces false positive rates, study shows
(American Roentgen Ray Society) Rates of false positive breast cancer screening exams fell significantly after complete integration of diagnostic digital breast tomosynthesis (DBT), potentially leading to higher quality, lower costs, and fewer unnecessary biopsies, according to a study to be presented at the ARRS 2018 Annual Meeting, set for April 22-27 in Washington, DC. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 12, 2018 Category: International Medicine & Public Health Source Type: news

Opioid use increases risk for serious invasive pneumococcal infections
(American College of Physicians) Opioid use is associated with a significantly increased risk for serious invasive pneumococcal infections, such as pneumonia and meningitis. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 12, 2018 Category: Cancer & Oncology Source Type: news

Balancing the benefits and risks of electronic cigarettes
(Massachusetts General Hospital) Massachusetts General Hospital physician Nancy Rigotti, M.D., outlines what is and is not known about the risks and benefits of e-cigarettes in a commentary published in the Feb. 13 issue of Annals of Internal Medicine. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 12, 2018 Category: Cancer & Oncology Source Type: news

Study suggests way to attack deadly, untreatable nerve tumors
(Cincinnati Children's Hospital Medical Center) Genomic profiling of mostly untreatable and deadly nerve sheath tumors led scientists to test a possible therapeutic strategy that inhibited tumor growth in lab tests on human tumor cells and mouse models, according to research in the journal Cancer Cell. When the international team of researchers analyzed complete screens of genes and genetic material in malignant peripheral nerve sheath tumors (MPNSTs), it revealed previously unknown genetic information about the disease. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 12, 2018 Category: Cancer & Oncology Source Type: news

Study sheds new light on mechanism of breast cancer treatment resistance
(Dana-Farber Cancer Institute) A study by researchers at Dana-Farber Cancer Institute has illuminated a specific mechanism by which estrogen receptor-positive (ER+) breast cancers can become resistant to standard therapies and metastasize. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 12, 2018 Category: Cancer & Oncology Source Type: news

Medicaid expansion in Kentucky improves breast cancer care for women 20 to 64 years old
(American College of Surgeons) In Kentucky, one of the Medicaid expansion states, a University of Louisville study of breast cancer care has found a connection between Medicaid expansion and improved quality of breast cancer care, including an increase in diagnosis of early stage disease and greater utilization of breast-conserving surgery instead of more invasive operations such as mastectomy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 12, 2018 Category: Cancer & Oncology Source Type: news

Family history increases breast cancer risk in older women: Weighing screening options
(Georgetown University Medical Center) Family history of breast cancer continues to significantly increase chances of developing invasive breast tumors in aging women -- those ages 65 and older. The findings of a new study could impact mammography screening decisions later in life. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 12, 2018 Category: Cancer & Oncology Source Type: news

Cancer-fighting nanorobots programmed to seek and destroy tumors
(Arizona State University) In a major advancement in nanomedicine, Arizona State University (ASU) scientists, in collaboration with researchers from the National Center for Nanoscience and Technology (NCNST), of the Chinese Academy of Sciences, have successfully programmed nanorobots to shrink tumors by cutting off their blood supply. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 12, 2018 Category: Cancer & Oncology Source Type: news

Cancer killing clue could lead to safer and more powerful immunotherapies
(Walter and Eliza Hall Institute) The study, led by Dr Misty Jenkins from the Walter and Eliza Hall Institute of Medical Research, explains the crucial mechanisms by which CAR-T cell therapy is able to rapidly target and kill cancer cells, and why it may cause serious side effects. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 12, 2018 Category: Cancer & Oncology Source Type: news

Obesity associated with longer survival for men with metastatic melanoma
(University of Texas M. D. Anderson Cancer Center) Obese patients with metastatic melanoma who are treated with targeted or immune therapies live significantly longer than those with a normal body mass index (BMI), investigators report in a study published in Lancet Oncology of 1,918 patients in six independent clinical cohorts.This effect, referred to as the 'Obesity Paradox,' principally manifested itself in men, said Jennifer McQuade, M.D., lead author and instructor of Melanoma Medical Oncology at The University of Texas MD Anderson Cancer Center. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 12, 2018 Category: Cancer & Oncology Source Type: news

Smart bomb virus shows promise as brain tumor immunotherapy
(University of Texas M. D. Anderson Cancer Center) A common cold virus engineered to attack the most common and deadly of brain tumors allowed 20 percent of patients with recurrent glioblastoma to live for three years or longer, researchers from The University of Texas MD Anderson Cancer Center report on a phase I clinical trial in the Journal of Clinical Oncology. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 12, 2018 Category: Cancer & Oncology Source Type: news

How do children's cancer diagnoses affect parents' income?
(Wiley) A new study from Sweden found that social benefits often ease the financial burdens experienced by the parents of children recently diagnosed with cancer, but mothers experienced persistently lower income after benefits diminished. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings indicate that additional efforts may be needed to address the financial hardships experienced by the mothers of children with cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 12, 2018 Category: Cancer & Oncology Source Type: news

Science self-corrects: Cancer gene does not pass reproducibility test
(Cold Spring Harbor Laboratory) About 10 years ago, several labs discovered that a gene called MELK is overexpressed, or turned on to a high degree, in many cancer cell types. This evidence has prompted multiple ongoing clinical trials to test whether drugs that inhibit MELK can treat cancer in patients. Now, CSHL researchers report that MELK is not actually involved in cancer. It's a story about how science self-corrects. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 12, 2018 Category: Cancer & Oncology Source Type: news

Cancer drug development award given to Jean-Charles Soria
(European Society for Medical Oncology) The TAT 2018 Honorary Award for cancer drug development has been granted to Professor Jean-Charles Soria, for his pioneering role in cancer drug development across molecular targeted agents, precision medicine, and immunotherapy. The award will be presented during the International Congress on Targeted Anticancer Therapies (TAT) 2018, to be held in Paris, France, March 5-7. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - February 12, 2018 Category: International Medicine & Public Health Source Type: news

Lung cancer drug resistance explained by computer simulations
(University of Bristol) Scientists from the Universities of Bristol and Parma, Italy, have used molecular simulations to understand resistance to osimertinib -- an anticancer drug used to treat types of lung cancer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 12, 2018 Category: International Medicine & Public Health Source Type: news

Researchers inhibit cancer metastases via novel steps
(Case Western Reserve University) In one of the first successes of its kind, researchers have inhibited the spreading of cancer cells from one part of the body to another. In doing so, they relied on a new model of how cancer metastasizes that emphasizes epigenetics, which examines how genes are turned on and off. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 12, 2018 Category: International Medicine & Public Health Source Type: news

Neutron study of glaucoma drugs offers clues about enzyme targets for aggressive cancers
(DOE/Oak Ridge National Laboratory) A team of researchers from ORNL's Energy and Transportation Science Division is using neutron imaging to study particulate filters that collect harmful emissions in vehicles. A better understanding of how heat treatments and oxidation methods can remove layers of soot and ash from these filters could lead to improved fuel-efficiency. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 12, 2018 Category: International Medicine & Public Health Source Type: news

Novel classification can lead to new ways to diagnose and treat cancer
(Baylor College of Medicine) A novel approach to studying cancer has enabled researchers to group about 10,000 human cancers of 32 different types into 10 classes based on the molecular pathways that drive tumor growth. A better understanding of these pathways can potentially lead to novel ways to diagnose and treat cancer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 12, 2018 Category: International Medicine & Public Health Source Type: news

Huntington's disease provides new cancer weapon
(Northwestern University) Patients with Huntington's disease, a fatal genetic illness that causes the breakdown of nerve cells in the brain, have up to 80 percent less cancer than the general population. Scientists have discovered why Huntington's is so toxic to cancer cells and harnessed it for a novel approach to treat cancer, a new study reports. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 12, 2018 Category: Cancer & Oncology Source Type: news

NIR light may identify breast cancer patients who will benefit most from chemotherapy
(Columbia University School of Engineering and Applied Science) A new optical imaging system developed at Columbia University uses red and near-infrared light to identify breast cancer patients who will respond to chemotherapy. The imaging system may be able to predict response to chemotherapy as early as two weeks after beginning treatment. Findings from a first pilot study of the new imaging system -- a noninvasive method of measuring blood flow dynamics in response to a single breath hold -- were published today in Radiology. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 12, 2018 Category: International Medicine & Public Health Source Type: news

New technology enables identification of biomarkers for a wide range of diseases
(Medical College of Georgia at Augusta University) Scientists have developed a way to identify biomarkers for a wide range of diseases by assessing the antibodies we are making to the complex sugars coating our cells.The new, highly sensitive Luminex Multiplex Glycan Array enables the kind of volume needed to establish associations between antibody levels in our blood to these complex sugars, or glycans, and conditions from cancer to autoimmune disease and dementia, they report in the journal Nature Communications. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 12, 2018 Category: International Medicine & Public Health Source Type: news

Blood Profiling Atlas in Cancer Consortium (BloodPAC) Announces...
On the One-Year Anniversary, Public Release of First Harmonized Datasets Will Open New Opportunities for Innovation and Collaboration.(PRWeb February 12, 2018)Read the full story at http://www.prweb.com/releases/2018/02/prweb15194915.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 12, 2018 Category: Pharmaceuticals Source Type: news

Campaigners urge vaccinating boys against HPV Virus
The Throat Cancer Foundation argues the policy is blatant sex discrimination and will condemn thousands to a painful death or months of gruelling treatment in adulthood. (Source: the Mail online | Health)
Source: the Mail online | Health - February 11, 2018 Category: Consumer Health News Source Type: news

New drug for women with 'Angelina Jolie' cancer
Lead researcher Jennifer Litton, Associate Professor at The University of Texas MD said: ‘This is game-changing because patients would always rather take a daily pill than go to hospital for chemo.' (Source: the Mail online | Health)
Source: the Mail online | Health - February 11, 2018 Category: Consumer Health News Source Type: news